Loading...
XNAS
CLPT
Market cap536mUSD
Jul 09, Last price  
17.88USD
1D
3.41%
1Q
105.99%
Jan 2017
425.88%
IPO
347.00%
Name

Clearpoint Neuro Inc

Chart & Performance

D1W1MN
XNAS:CLPT chart
P/E
P/S
14.50
EPS
Div Yield, %
Shrs. gr., 5y
12.31%
Rev. gr., 5y
23.58%
Revenues
37m
+17.78%
2,669,4503,818,1665,058,2353,930,5753,604,4824,594,1925,749,4547,379,5257,353,26611,217,00012,829,00016,299,00020,551,00023,955,00031,390,00036,971,000
Net income
-26m
L+35.03%
-9,454,235-8,311,411-5,707,136-7,086,274-4,524,732-8,449,246-8,069,895-7,167,353-6,163,469-5,540,000-6,782,000-14,410,000-16,435,000-22,089,000-18,914,000-25,540,000
CFO
-24m
L+167.32%
-7,707,253-6,239,595-7,433,816-7,777,931-7,250,303-8,637,734-5,820,043-5,992,511-4,630,592-2,849,514-7,808,000-12,697,000-16,167,000-13,720,000-8,950,000-23,925,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
IPO date
Jul 03, 2019
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT